This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by COULOMBE, P. Articles by WALKER, P. Search for Related Content PubMed PubMed Citation Articles by COULOMBE, P. Articles by WALKER, P.

Catecholamine Metabolism in Thyroid Disease. II. Norepinephrine Secretion Rate in Hyperthyroidism and Hypothyroidism

Service d'Endocrinologie et Metabolisme, Centre Hospitalier de I'Universite Laval Quebec, Canada

Reprint requests to: Jean H. Dussault, M.D., Le Centre Hospitalier de I'Universite Laval, 2705, boul. Laurier, Quebec, Canada G1V 4G2.

We have measured the secretion rate of norepinephrine (NE) in 6 euthyroid subjects, 6 hyperthyroid and 6 hypothyroid patients, infused at a constant rate (0.1 µC/kg/min) for 1 h with tritiated norepinephrine (New England Nuclear Inc.). Plasma NE concentrations were measured by a modification of the fluorometric method of Anton and Sayre. A significant linear relationship was observed between plasma NE and age in normal subjects. Accordingly, values for plasma NE have been corrected for age. Plasma NE concentration was 18.3 ± 4.2 ng/100 ml (mean ± SEM) in normal subjects compared with 17.5 ± 3.3 ng/100 ml in hyperthyroid patients. There was a significant elevation of plasma NE (30.3 ± 2.9 ng/100 ml) in hypothyroid patients (P < 0.05). A significant elevation was observed in plasma NE secretion rates in hypothyroidism 4.62 ±0.98 µg/kg/day (P < 0.02) when compared to the control group (1.46 ± 0.35 µg/kg/ day). No significant difference was observed between the hyperthyroid group (1.74 ± 0.49 µg/kg/day) and the controls. These data indicate that the plasma NE secretion rate is normal in hyperthyroidism, and is significantly elevated in hypothyroidism thereby explaining the higher plasma NE concentrations seen in hypothyroidism.

Supported by Quebec Medical Research Council grant no. 720-050.

Received December 1, 1976.

This article has been cited by other articles:

				J. E. Silva Thermogenic Mechanisms and Their Hormonal Regulation Physiol Rev, April 1, 2006; 86(2): 435 - 464. [Abstract] [Full Text] [PDF]

				J. E. Sprague, M. L. Banks, V. J. Cook, and E. M. Mills Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 159 - 166. [Abstract] [Full Text]

				H. Pijl, P. H. E. M. de Meijer, J. Langius, C. I. G. M. Coenegracht, A. H. M. van den Berk, P. K. Chandie Shaw, H. Boom, R. C. Schoemaker, A. F. Cohen, J. Burggraaf, et al. Food Choice in Hyperthyroidism: Potential Influence of the Autonomic Nervous System and Brain Serotonin Precursor Availability J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5848 - 5853. [Abstract] [Full Text] [PDF]

				J. Burggraaf, J. H. M. Tulen, S. Lalezari, R. C. Schoemaker, P. H. E. M. De Meyer, A. E. Meinders, A. F. Cohen, and H. Pijl Sympathovagal imbalance in hyperthyroidism Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E190 - E195. [Abstract] [Full Text] [PDF]

				H. Ashikaga, R. Abreu, and R. F. Schneider Propanolol Administration in a Patient with Thyroid Storm Ann Intern Med, April 18, 2000; 132(8): 681 - 682. [Full Text] [PDF]

				H. Al-Adsani, L. J. Hoffer, and J. E. Silva Resting Energy Expenditure is Sensitive to Small Dose Changes in Patients on Chronic Thyroid Hormone Replacement J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1118 - 1125. [Abstract] [Full Text] [PDF]

				E. Roti, M. Montermini, S. Roti, E. Gardini, G. Robuschi, R. Minelli, M. Salvi, M. Bentivoglio, U. Guiducci, and L. E. Braverman The Effect of Diltiazem, a Calcium Channel--Blocking Drug, on Cardiac Rate and Rhythm in Hyperthyroid Patients Arch Intern Med, September 1, 1988; 148(9): 1919 - 1921. [Abstract] [PDF]

				P. H. Gerst, J. Fildes, P. Baylor, and J. Zonszein Long-Acting {beta}-Adrenergic Antagonists as Preparation for Surgery in Thyrotoxicosis Arch Surg, July 1, 1986; 121(7): 838 - 840. [Abstract] [PDF]

				M. M. Barsotti, J. H. Targovnik, and T. A. Verso Thyrotoxicosis, Hypercalcemia, and Secondary Hyperparathyroidism Arch Intern Med, June 1, 1979; 139(6): 661 - 663. [Abstract] [PDF]